CONSHOHOCKEN, PA — Suvoda said its interactive response technology software has been named a Leader in Everest Group’s PEAK Matrix assessment for randomization and trial supply management, a recognition that highlights the company’s growing role in managing complex clinical trials.
Everest Group’s PEAK Matrix is a data-driven evaluation that measures technology providers on market impact as well as vision and delivery capability. The assessment incorporates customer interviews to gauge real-world performance and user experience, positioning Suvoda among the top-tier providers in the RTSM category.
Everest cited Suvoda’s strength in handling high-complexity and multi-arm studies, pointing to its low-code and no-code configuration tools, modular architecture, and broad integration capabilities. The firm also noted Suvoda’s continued investment in automation and artificial intelligence as factors behind its Leader designation in the 2025 Life Sciences RTSM Products PEAK Matrix.
Suvoda’s IRT platform functions as a central control system for clinical trial logistics, helping sponsors, contract research organizations, and trial sites manage patient randomization and drug supply with real-time visibility. The system supports adaptive protocols and can be adjusted during active trials, a capability that has become increasingly important as study designs grow more complex.
Company executives said the recognition reflects both technical depth and execution speed. Jagath Wanninayake, chief executive officer of Suvoda, said the platform is designed to support the most time-sensitive moments of a trial by tightly linking randomization, inventory management, and broader study operations.
Suvoda has also expanded its platform with Sofia, an AI-powered assistant intended to simplify drug supply management. The tool enables users to retrieve data, monitor inventory levels, review visit schedules, and generate visual reports through a conversational interface, giving trial teams faster access to actionable insights.
As clinical trials increasingly rely on adaptive designs and global supply chains, technology that can scale and adjust mid-study has become a competitive differentiator. Suvoda said its latest recognition reflects a broader industry shift toward more flexible, data-driven trial management systems built to reduce risk and improve execution across the clinical development lifecycle.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.